We are live on ! Find out more
INM icon

InMed Pharmaceuticals
INM

11 hedge funds and large institutions have $117K invested in InMed Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.3% less ownership

Funds ownership: 0.57% → 0.26% (-0.3%)

27% less funds holding

Funds holding: 15 → 11 (-4)

50% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 8

53% less capital invested

Capital invested by funds: $249K → $117K (-$133K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
11
Holders Change
-4
Holders Change %
-26.67%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
–
Reduced
2
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$24.8K
2
XT
XTX Topco
Cayman Islands
+$5.09K
3
HF
HRT Financial
New York
+$4.57K
4
TWC
TD Waterhouse Canada
Ontario, Canada
+$23

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$97.2K
2
SM
Sabby Management
Florida
-$15.6K
3
Renaissance Technologies
Renaissance Technologies
New York
-$10K
4
TSS
Two Sigma Securities
New York
-$5.61K
5
Citadel Advisors
Citadel Advisors
Florida
-$177
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$81.6K -$15.6K -2,724 -15%
VF
2
Virtu Financial
New York
$23K +$24.8K +4,334 New
XT
3
XTX Topco
Cayman Islands
$4.73K +$5.09K +891 New
HF
4
HRT Financial
New York
$4K +$4.57K +800 New
Citadel Advisors
5
Citadel Advisors
Florida
$3.21K -$177 -31 -5%
Qube Research & Technologies (QRT)
6
Qube Research & Technologies (QRT)
United Kingdom
$54 – – –
Bank of America
7
Bank of America
North Carolina
$26 – – –
TWC
8
TD Waterhouse Canada
Ontario, Canada
$21 +$23 +4 New
Osaic Holdings
9
Osaic Holdings
Arizona
$7 – – –
AWM
10
AllSquare Wealth Management
New York
$6 – – –
GRP
11
Global Retirement Partners
California
$2 – – –
Toronto Dominion Bank
12
Toronto Dominion Bank
Ontario, Canada
$1 – – –
AC
13
Armistice Capital
New York
– -$97.2K -13,348 Closed
Renaissance Technologies
14
Renaissance Technologies
New York
– -$10K -1,415 Closed
TSS
15
Two Sigma Securities
New York
– -$5.61K -771 Closed
BL
16
BFSG LLC
California
– -$73 -10 Closed
AF
17
Advisornet Financial
Minnesota
– -$29 -4 Closed
UBS Group
18
UBS Group
Switzerland
– -$15 -2 Closed
FDCDDQ
19
Federation des caisses Desjardins du Quebec
Quebec, Canada
– -$7 -1 Closed
National Bank of Canada
20
National Bank of Canada
Quebec, Canada
– -$3 -1 Closed

INM Hedge Fund Activity: Q2 2024 in Review

11 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in InMed Pharmaceuticals (INM) for Q2 2024, worth a combined $117K — down 53% from $249K a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of INM and 4 opened new positions — a net loss of 4 holders — while 2 trimmed existing stakes and 0 added.

The largest buyer was Virtu Financial, opening a new position worth an estimated $24.8K. The largest seller was Armistice Capital, exiting entirely with an estimated $97.2K sold.

  • 11 institutional investors held InMed Pharmaceuticals (INM) as of Q2 2024, down from 15 in Q1 2024.
  • Funds reported $117K of InMed Pharmaceuticals stock for Q2 2024, down 53% quarter-over-quarter.
  • 4 funds opened new InMed Pharmaceuticals positions in Q2 2024 and 8 closed out, a net change of -4 holders.
  • The largest InMed Pharmaceuticals buyer in Q2 2024 was Virtu Financial, an estimated $24.8K added.
  • The largest InMed Pharmaceuticals seller in Q2 2024 was Armistice Capital, an estimated $97.2K sold.

Based on aggregated 13F filings for Q2 2024.